Sorin drops $20m on stake in Respicardia
October 22, 2014 by Alexander Soule
Sorin Group drops $20 million on a stake in Minnetonka, Minn.-based Respicardia, which is developing implantable devices to treat central sleep apnea.
Sorin Group (BIT:SRN) said it invested $20 million in a minority stake and controlling option in Minnetonka, Minn.-based Respicardia, which is developing implantable devices to treat central sleep apnea.
Milan, Italy-based Sorin also said it won CE Mark approval for its new Memo 3D ReChord mitral valve annuloplasty device.
In exchange for its investment in Respicardia, Sorin gets an exclusive option to acquire the company and exclusive rights to distribute Respicardia's Remedē system for 5 years in parts of Europe.
In the past 14 months, Respicardia had disclosed $17 million in funding; past investors in the company include Three Arch Partners, Versant Ventures, Polaris Ventures Partners, Accuitive Medical Ventures and Affinity Capital Management.
Similar entries
• 1st patients enroll in Respicardia's trial for sleep apnea implant
The Remedē system is a pacemaker-like device that delivers electrical pulses via an implantable transvenous lead to the phrenic nerve to restore a more natural and less-disrupted breathing pattern. The device received CE Mark approval in 2010 and is currently being evaluated in an FDA trial.
Central sleep apnea disturbs the normal breathing pattern during sleep with an impact on cardiovascular health, affecting more than 5 million patients worldwide. More than a 3rd of heart failure patients suffer from central sleep apnea.
"Together with our [cardiac rhythm management] devices and our neuromodulation platform under development, this investment further demonstrates our commitment to developing innovative solutions for heart failure patients," CEO André-Michel Ballester said in prepared remarks.
Sounds like real "fun" being SHOCKED each time you have an apnea event! I'm not sure which would be worse, the loss of sleep from the apnea or the loss of sleep from the electrical jolts
Sorin drops $20m on stake in Respicardia
- Sleepy Veteran
- Posts: 12
- Joined: Sat Sep 13, 2014 9:35 pm
- Location: Tampa Florida
Sorin drops $20m on stake in Respicardia
_________________
Machine | Mask | |||
![]() | ![]() | |||
Additional Comments: All CPAP equipment provided by the United States Veterans Administration HOORAH! |
"Simple incompetence is generally a far more sinister force than malicious intent."
-
- Posts: 2744
- Joined: Tue Oct 12, 2010 6:42 pm
Re: Sorin drops $20m on stake in Respicardia
It's all a matter of perspective...
How sensitive are you to the "jolt" you receive every time your heart beats?
How sensitive are you to the "jolt" you receive every time your heart beats?
_________________
Mask: Brevida™ Nasal Pillow CPAP Mask with Headgear |
Additional Comments: Machine is an AirSense 10 AutoSet For Her with Heated Humidifier. |
SpO2 96+% and holding...
Re: Sorin drops $20m on stake in Respicardia
Seems like a major step forward for central apnea patients if it works. First true "out of the box" advance in apnea treatment since CPAP?
_________________
Mask: Quattro™ FX Full Face CPAP Mask with Headgear |
Humidifier: S9™ Series H5i™ Heated Humidifier with Climate Control |
Additional Comments: ResScan 4.3 software, 50D+ Oximeter |
Re: Sorin drops $20m on stake in Respicardia
Big difference, your heart does not have nerves so you do not feel the "Jolts".HoseCrusher wrote:It's all a matter of perspective...
How sensitive are you to the "jolt" you receive every time your heart beats?
_________________
Mask: AirFit™ P10 Nasal Pillow CPAP Mask with Headgear |
Humidifier: S9™ Series H5i™ Heated Humidifier with Climate Control |
-
- Posts: 28
- Joined: Mon Apr 28, 2014 11:18 am
Re: Sorin drops $20m on stake in Respicardia
this is for hard to treat apnea. Central apneas and apneas that arn't easily controlled with pap.
Re: Sorin drops $20m on stake in Respicardia
Anyone that's having centrals will probably be grateful to feel the jolt.